Trinity Biotech (TRIB) Inventory (2009 - 2025)

Trinity Biotech (TRIB) has reported Inventory for 17 consecutive years, with $18.8 million the latest figure, recorded in Q4 2025.

• Quarterly Inventory fell 2.82% year-over-year to $18.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $18.8 million (down 2.82% YoY) and the FY2025 annual result came in at $18.8 million, down 2.82% from the prior year.
• Inventory fell to $18.8 million in Q4 2025 per TRIB's latest filing, from $20.1 million in the prior quarter.
• Over the last five years, Inventory for TRIB reached as high as $37.6 million in Q1 2021 and fell as low as $1.2 million in Q4 2023.
• A 5-year average of $23.9 million and a median of $22.6 million in 2023 frame the typical range for Inventory.
• Annual changes were most pronounced in 2023 — Inventory slumped 94.85% — and 2024, when it surged 1570.17%.
• Year by year, Inventory stood at $29.1 million in 2021, then slipped by 22.73% to $22.5 million in 2022, then sank by 94.85% to $1.2 million in 2023, then jumped by 1570.17% to $19.4 million in 2024, then slipped by 2.82% to $18.8 million in 2025.
• According to Business Quant data, Inventory over the past three periods registered $18.8 million, $20.1 million, and $19.4 million for Q4 2025, Q2 2025, and Q4 2024 respectively.